1. Home
  2. OCC vs ACRV Comparison

OCC vs ACRV Comparison

Compare OCC & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Optical Cable Corporation

OCC

Optical Cable Corporation

HOLD

Current Price

$5.57

Market Cap

48.8M

Sector

Industrials

ML Signal

HOLD

Logo Acrivon Therapeutics Inc.

ACRV

Acrivon Therapeutics Inc.

HOLD

Current Price

$1.54

Market Cap

56.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OCC
ACRV
Founded
1983
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.8M
56.5M
IPO Year
2001
2022

Fundamental Metrics

Financial Performance
Metric
OCC
ACRV
Price
$5.57
$1.54
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$13.00
AVG Volume (30 Days)
93.5K
729.1K
Earning Date
03-20-2026
04-20-2026
Dividend Yield
N/A
N/A
EPS Growth
290.91
13.14
EPS
N/A
N/A
Revenue
$87,828,590.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$805.34
P/E Ratio
N/A
N/A
Revenue Growth
37.03
N/A
52 Week Low
$2.40
$1.05
52 Week High
$11.50
$5.75

Technical Indicators

Market Signals
Indicator
OCC
ACRV
Relative Strength Index (RSI) 49.28 41.92
Support Level $4.19 $1.51
Resistance Level $5.98 $2.47
Average True Range (ATR) 0.72 0.12
MACD 0.02 0.03
Stochastic Oscillator 18.44 17.17

Price Performance

Historical Comparison
OCC
ACRV

About OCC Optical Cable Corporation

Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

Share on Social Networks: